• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16376 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2000     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) A systematic review of laparoscopic live donor nephrectomy (re-appraisal)
2000     VA Technology Assessment Program (VATAP) Tablet splitting
2000     Institute for Clinical Systems Improvement (ICSI) Gastric restrictive surgery for morbid obesity
2000     HAYES, Inc. Estrogen pellet implants
2000     Agency for Healthcare Research and Quality (AHRQ) Prediction of risk for patients with unstable angina
2000     HAYES, Inc. Extracorporeal immunoadsorption using protein A columns (prosorba) for the treatment of rheumatoid arthritis
2000     The Swedish Council on Health Technology Assessment (SBU) Antiplatelet agents - clopidogrel (Plavix) - early assessment briefs (ALERT)
2000     The Swedish Council on Health Technology Assessment (SBU) Autologous chondrocyte transplantation in treating cartilage damage in the knee - early assessment briefs (ALERT)
2000     The Swedish Council on Health Technology Assessment (SBU) Brachytherapy for prostatic cancer - early assessment briefs (ALERT)
2000     HAYES, Inc. Fetal fibronectin test
2000     The Swedish Council on Health Technology Assessment (SBU) Therapeutic drug monitoring in epilepsy treatment - early assessment briefs (ALERT)
2000     The Swedish Council on Health Technology Assessment (SBU) Viagra for impotence - early assessment briefs (ALERT)
2000     Institute for Clinical Systems Improvement (ICSI) Tocolytic therapy for preterm labor
2000     Institute for Clinical Systems Improvement (ICSI) Transmyocardial laser therapy for severe refractory angina
2000     The Swedish Council on Health Technology Assessment (SBU) Lymphatic mapping and sentinel node biopsy in breast cancer - early assessment briefs (ALERT)
2000     HAYES, Inc. Helical computed tomography for coronary artery disease
2000     The Swedish Council on Health Technology Assessment (SBU) Presymptomatic diagnosis of hereditary breast cancer - early assessment briefs (ALERT)
2000     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Use of cisapride in patients with non-ulcer dyspepsia: a meta-analysis of randomized trials
2000     HAYES, Inc. Hepatitis A vaccine
2000     Centre for Clinical Effectiveness (CCE) Is smoke plume from laser/electric surgical procedures a health hazard?
2000     Centre for Clinical Effectiveness (CCE) What is the incidence of temporary epicardial pacemakers requiring troubleshooting?
2000     HAYES, Inc. High-density lipoprotein subclass testing for screening, diagnosis, and management of dyslipidemia and cardiovascular disease
2000     Centre for Clinical Effectiveness (CCE) Does single dose dexamethasone prevent relapse after emergency department treatment of acute migraine?
2000     HAYES, Inc. High-dose chemotherapy and radiation therapy followed by allogeneic transplantation for multiple myeloma
2000     Centre for Clinical Effectiveness (CCE) What is the optimal positioning for patients with drug induced or non drug induced partial or total paralysis in intensive care unit?
2000     HAYES, Inc. High-dose chemotherapy with allogeneic stem cell/support, treatment for neuroblastoma
2000     Centre for Clinical Effectiveness (CCE) The diagnostic characteristics of transvaginal ultrasound in the detection of endometrial cancer in postmenopausal women taking hormone replacement therapy
2000     HAYES, Inc. High-dose chemotherapy with autologous stem cell support, treatment for breast cancer
2000     Centre for Clinical Effectiveness (CCE) Prophylactic beta-adrenergic blocking agents given perioperatively for preventing post-operative cardiac adverse events
2000     HAYES, Inc. High-dose chemotherapy with autologous stem cell support, treatment for neuroblastoma
2000     Centre for Clinical Effectiveness (CCE) Nurse-initiation of x-rays of possible limb fractures in hospital emergency departments
2000     HAYES, Inc. High-dose chemotherapy with peripheral stem cell/autologous rescue, treatment for non-CNS pediatric solid tumors other than neuroblastoma
2000     ECRI Gene therapy for intractable ischemic health disease
2000     Centre for Clinical Effectiveness (CCE) What is the prevalence of social skill, speech and language deficits in adolescents with significant psychiatric mental health problems?
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Oxifirst (TM)
2000     Centre for Clinical Effectiveness (CCE) The bleeding patterns which can occur with long term hormone replacement therapy (HRT) and how they correlate with endometrial pathology
2000     HAYES, Inc. High-frequency chest wall compression
2000     University of York Complications of diabetes: renal disease and promotion of self-management
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Mini tracheotomy
2000     Centre for Clinical Effectiveness (CCE) Observations for normal term neonates
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Da Vinci (TM) surgical system
2000     Centre for Clinical Effectiveness (CCE) Is carotid stenting for carotid stenosis effective for stroke prevention compared with carotid endarterectomy?
2000     Alberta Heritage Foundation for Medical Research (AHFMR) FolateScan
2000     Centre for Clinical Effectiveness (CCE) How effective are computer assisted decision support systems (CADSS) in improving clinical outcomes of patients?
2000     Alberta Heritage Foundation for Medical Research (AHFMR) BreastCare (TM)/BreastAlert (TM)
2000     Centre for Clinical Effectiveness (CCE) Effectiveness of thoracotomy versus thoracoscopy (VATS) in the management of paediatric empyema
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Retinal tissue transplant
2000     ECRI High-frequency chest compression for cystic fibrosis
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Digital Response (R) HbA1c Patient Monitor
2000     HAYES, Inc. Homocysteine testing for screening, diagnosis, and management of dyslipidemia and cardiovascular disease
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Somnoplasty (R) system
2000     Alberta Heritage Foundation for Medical Research (AHFMR) HomeMed Monitoring System (TM)
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Lifestream Technologies (TM) cholesterol monitor
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Hemolink (TM)
2000     Alberta Heritage Foundation for Medical Research (AHFMR) FocalSeal-L
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Needle laser ablation
2000     Alberta Heritage Foundation for Medical Research (AHFMR) 'Soft copy' digital mammography
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Practitioner-initiated advice provided to patients through electronic modes
2000     Alberta Heritage Foundation for Medical Research (AHFMR) OssaTron (R) extracorporeal shock wave device
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Metal-on-metal surface replacement of the hip for congenital hip dysplasia
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Ingestible imaging capsule
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Allogeneic stem cell transplantation methods
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Cardiac navigation system
2000     HAYES, Inc. In vitro extreme drug resistance assays in cancer treatment
2000     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Neonatal screening for cystic fibrosis
2000     Alberta Heritage Foundation for Medical Research (AHFMR) BLU-U (TM) Blue Light Photodynamic Therapy Illuminator
2000     Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Implantable ventricular assistance devices: should they be used in Quebec?
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Health expenditure and technology in the treatment of heart attacks (HEAT 3). (Third in a series on the Health Expenditure and Technology project, jointly with the Institute of Health Economics)
2000     Alberta Heritage Foundation for Medical Research (AHFMR) A technology index of hospital expenditure growth in Canada (HEAT 4). (Fourth in a series on the Health Expenditure and Technology project, jointly with the Institute of Health Economics)
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Overview of the project (HEAT 5). (Fifth in a series on the Health Expenditure and Technology project, jointly with the Institute of Health Economics)
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Visudyne (TM) therapy for the treatment of age-related macular degeneration
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Chemoembolization treatment for colorectal metastases to the liver
2000     HAYES, Inc. Intracoronary radiation therapy
2000     Agency for Healthcare Research and Quality (AHRQ) Diagnosis and treatment of uncomplicated acute sinusitis in children
2000     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) A systematic review of ultrasound-assisted lipoplasty (update and re-appraisal)
2000     Agency for Healthcare Research and Quality (AHRQ) Determinants of disability in patients with chronic renal failure
2000     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) A systematic review of lung volume reduction surgery (update and re-appraisal)
2000     HAYES, Inc. Intravenous immunoglobulin for hematological diseases
2000     Agency for Healthcare Research and Quality (AHRQ) Management of chronic hypertension during pregnancy
2000     HAYES, Inc. Intravenous immunoglobulin for neurological diseases
2000     HAYES, Inc. Intravenous immunoglobulin for pediatric AIDS
2000     Agency for Healthcare Research and Quality (AHRQ) Management of preterm labour. Volume 1: Evidence report and appendixes; Volume 2: Evidence tables
2000     HAYES, Inc. Intravenous immunoglobulin for pulmonary diseases
2000     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) A systematic review of minimally invasive techniques for the relief of bladder outflow obstruction (update and re-appraisal)
2000     HAYES, Inc. Intravenous immunoglobulin for rheumatic diseases
2000     Agency for Healthcare Research and Quality (AHRQ) Garlic: effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects
2000     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Health registers - how, why and for whom?
2000     Health Council of the Netherlands Gezondheidsraad (GR) Intensive care at birth
2000     Agency for Healthcare Research and Quality (AHRQ) Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects
2000     Agency for Healthcare Research and Quality (AHRQ) Prevention of venous thromboembolism after injury
2000     Institute for Clinical Evaluative Sciences (ICES) An examination of how hospitals use the reporting framework prescribed in the Ontario Hospital Reporting System
2000     Medical Services Advisory Committee (MSAC) Hyperbaric oxygen therapy
2000     Agency for Healthcare Research and Quality (AHRQ) Criteria for weaning from mechanical ventilation
2000     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) The patient in the data network - advantages and risks of computer-based patient records. Short version of the TA-study 'Computer-based patient records'
2000     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Between the pantry and the pharmacy: functional food - a grey area. Short version of the TA-study 'functional food'.
2000     Medical Services Advisory Committee (MSAC) Sacral nerve stimulation for refractory urinary urge incontinence or urinary retention
2000     Medical Services Advisory Committee (MSAC) Funding for new medical technologies and procedures: application and assessment guidelines
2000     West Midlands Health Technology Assessment Collaboration (WMHTAC) Antiretroviral therapy for HIV infection in patients naive to prior treatment: a systematic review of effectiveness and cost-effectiveness
2000     University HealthSystem Consortium (UHC) Antidiabetic agents
2000     Agency for Healthcare Research and Quality (AHRQ) Small bowel transplantation